BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Deals

  Diagnostic Player, Veracyte, Inc., Pulls Off $65 Million IPO

  October 31, 2013

   · 

  2 min read
• Pharm Country

  Svelte Medical Systems, Inc. Scores an Additional $22 Million

  October 31, 2013

   · 

  3 min read
• Policy

  Feds Quiz AstraZeneca PLC Over Brilinta Clinical Trial

  October 31, 2013

   · 

  1 min read
• Drug Development

  New Two-Hormone Roche Drug Shows Promise in Diabetes, Obesity

  October 31, 2013

   · 

  1 min read
• Bio NC

  VC Firm NovaQuest, Raises $459 Million Fund Focused on Pharma Opportunities

  October 31, 2013

   · 

  2 min read
• Pharm Country

  Nephros Inc. Plummets 68% on Filter Recall

  October 31, 2013

   · 

  1 min read
• Policy

  U.S. Appeals Court Revives Patent Fight Over AstraZeneca PLC Drug

  October 31, 2013

   · 

  1 min read
• Pharm Country

  Blame the “Chaperone": The Jackson Laboratory Researchers Find Mutation in “Chaperone” Proteins That Lead to Major Developmental Abnormalities

  October 31, 2013

   · 

  2 min read
• Deals

  Reckitt Benckiser Heroin-Abuse Drug Seen Luring Shire plc, Other Bidders

  October 31, 2013

   · 

  1 min read
• Pharm Country

  Tosoh Bioscience LLC Announces New High Capacity TOYOPEARL® Protein A Resin

  October 31, 2013

   · 

  1 min read